Effects of lycopene on the initial state of atherosclerosis in new zealand white (nzw) rabbits

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Lorenz, Mario ^a   Fechner, Mandy ^a   Kalkowski, Janine ^a   Fröhlich, Kati ^b,c   Trautmann, Anne ^b   Böhm, Volker ^b   Liebisch, Gerhard ^d   Lehneis, Stefan ^d   Schmitz, Gerd ^d   Ludwig, Antje ^a   Baumann, Gert ^a   Stangl, Karl ^a   Stangl, Verena ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c JenaWave GmbH Jena   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; PLACEBO; REDIVIVO; UNCLASSIFIED DRUG; CAROTENOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTICLE; BIOACCUMULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; ISOLATED ORGAN; LIPID STORAGE; MALE; NONHUMAN; RABBIT; STEROL ANALYSIS; TISSUE CHARACTERIZATION; ANIMAL; AORTA; ATHEROSCLEROSIS; BLOOD; DIET SUPPLEMENTATION; INTIMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASODILATATION;

ANIMALIA; LYCOPERSICON ESCULENTUM; ORYCTOLAGUS CUNICULUS;

ANIMALS; AORTA; ATHEROSCLEROSIS; CAROTENOIDS; CHOLESTEROL ESTERS; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; MALE; RABBITS; TUNICA INTIMA; VASODILATION;

EID: 84856290189     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030808     Document Type: Article

References (31)

1. Blum A, Monir M, Wirsansky I, Ben-Arzi S, (2005) The beneficial effects of tomatoes. Eur J Intern Med 16: 402-404.
2. Rissanen T, Voutilainen S, Nyyssönen K, Salonen JT, (2002) Lycopene, atherosclerosis, and coronary heart disease. Exp Biol Med 227: 900-907.
3. Mordente A, Guantario B, Meucci E, Silvestrini A, Lombardi E, et al. (2011) Lycopene and cardiovascular diseases: An update. Curr Med Chem 18: 1146-1163.
4. Palozza P, Parrone N, Simone RE, Catalano A, (2010) Lycopene in atherosclerosis prevention: An integrated scheme of the potential mechanisms of action from cell culture studies. Arch Biochem Biophys 504: 26-33.
5. Kelkel M, Schumacher M, Dicato M, Diederich M, (2011) Antioxidant and anti-proliferative properties of lycopene. Free Radic Res doi:10.3109/10715762.2011.564168.
6. Klipstein-Grobusch K, Launer LJ, Geleijnse JM, Boeing H, Hofman A, et al. (2000) Serum carotenoids and atherosclerosis. The Rotterdam Study. Atherosclerosis 148: 49-56.
7. Gianetti J, Pedrinelli R, Petrucci R, Lazzerini G, De Caterina M, et al. (2002) Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J 143: 467-474.
8. Riccioni G, D'Orazio N, Speranza L, Di Ilio E, Glade M, et al. (2010) Carotenoids and asymptomatic carotid atherosclerosis. J Biol Regul Homeost Agents 24: 447-452.
9. Karppi J, Kurl S, Laukkanen JA, Rissanen TH, Kauhanen J, (2011) Plasma carotenoids are related to intima-media thickness of the carotid artery wall in men from eastern Finland. J Intern Med doi:10.1111/j.1365-2796.2011.02401.
10. Kim OY, Yoe HY, Kim HJ, Park JY, Kim JY, et al. (2010) Independent inverse relationship between serum lycopene concentration and arterial stiffness. Atherosclerosis 208: 581-586.
11. Yeo HY, Kim OY, Lim HH, Kim JY, Lee JH, (2011) Association of serum lycopene and brachial-ankle pulse wave velocity with metabolic syndrome. Metabolism 60: 537-543.
12. Ried K, Fakler P, (2011) Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials. Maturitas 68: 299-310.
13. Yanni AE, (2004) The laboratory rabbit: An animal model of atherosclerosis research. Lab Anim 38: 246-256.
14. Bieri JG, Brown ED, Smith JC, (1985) Determination of individual carotenoids in human plasma by high performance liquid chromatography. J Liquid Chromatogr 8: 473-484.
15. Fröhlich K, Kaufmann K, Bitsch R, Böhm V, (2006) Effects of ingestion of tomatoes, tomato juice and tomato purée on contents of lycopene isomers, tocopherols and ascorbic acid in human plasma as well as on lycopene isomer pattern. Br J Nutr 95: 734-741.
16. Liebisch G, Binder M, Schifferer R, Langmann T, Schulz B, et al. (2006) High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochim Biophys Acta 1761: 121-128.
17. Wong SH, Knight JA, Hopfer SM, Zaharia O, Leach CN Jr, et al. (1987) Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33: 214-220.
18. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D, (2009) The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-analysis. Clin Ther 31: 236-244.
19. Preiss D, Sattar N, (2009) Lipids, lipid modifying agents and cardiovascular risk: A review of the evidence. Clin Endocrinol 70: 815-828.
20. Matsumoto I, Miyake Y, Mizukawa M, Takagi Y, (2011) Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Circ J 75: 905-910.
21. Hu MY, Li YL, Jiang CH, Liu ZQ, Qu SL, et al. (2008) Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits. Nutrition 24: 1030-1038.
22. Verghese M, Richardson JE, Boateng J, Shackelford LA, Howard C, et al. (2008) Dietary lycopene has a protective effect on cardiovascular disease in New Zealand male rabbits. J Biol Sci 8: 268-277.
23. Frederiksen H, Rasmussen SE, Schrøder M, Bysted A, Jakobsen J, et al. (2007) Dietary supplementation with an extract of lycopene-rich tomatoes does not reduce atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits. Br J Nutr 97: 6-10.
24. Tanzawa K, Shimada Y, Kuroda M, Tsujita Y, Arai M, et al. (1980) WHHL-rabbit: A low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett 118: 81-84.
25. Romanchik JE, Morel DW, Harrison EH, (1995) Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro. J Nutr 125: 2610-2617.
26. Palozza P, Simone R, Catalano A, Parrone N, Monego G, et al. (2011) Lycopene regulation of cholesterol synthesis and efflux in human macrophages. J Nutr Biochem doi:10.1016/j.jnutbio.2010.08.010.
27. Misra R, Mangi S, Joshi S, Mittal S, Gupta SK, et al. (2006) LycoRed as an alternative to hormone replacement therapy in lowering serum lipids and oxidative stress markers: A randomized controlled clinical trial. J Obstet Gynaecol Res 32: 299-304.
28. Engelhard YN, Gazer B, Paran E, (2006) Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: A double-blind, placebo-controlled pilot study. Am Heart J 151: 100.e1-100.e6.
29. Sun YP, Lu NC, Parmley WW, Hollenbeck CB, (2000) Effects of cholesterol diets on vascular function and atherogenesis in rabbits. Proc Soc Exp Biol Med 224: 166-171.
30. Rissanen TH, Voutilainen S, Nyyssönen K, Salonen R, Kaplan GA, et al. (2003) Serum lycopene concentrations and carotid atherosclerosis: The Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 77: 133-138.
31. Riccioni G, D'Orazio N, Scotti L, Petruzzelli R, Latino A, et al. (2010) Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: A case control study. Int J Immunopathol Pharmacol 23: 327-334.